Skip to main content

Revolution Medicines, Inc.

RVMDW
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001628171

In the last 90 days, Revolution Medicines, Inc. insiders filed 0 open-market purchases and 16 sales; 22 institutions reported holding it in 13F filings for Q2 2026, worth $93.0M in total; no superinvestor holds it.

Other share classesRVMD

Superinvestors holding RVMDW, Q2 2026

See all superinvestors

No superinvestor reported holding RVMDW in Q2 2026.